Haw Par Corporation Limited

H02.SI : Singapore Exchange

10.380

+0.48%

Share Price in SGD. As of 26 Jul 17:04:43 SGT

All

Chart

Key stats

  • 52-Week High
    SGD 10.490
  • 52-Week Low
    SGD 9.280
  • Market Cap
    SGD 2.3B
  • Avg Volume
    78K
  • P/E Ratio (TTM)
    10.59
  • Forward Dividend Yield
    3.9%

Share Price Performance

H02.SI
Market
1 Day 0.78% 0.24%
5 Day 1.57% -0.31%
1 Month 6.35% 2.49%
6 Month 9.26% 9.02%
YTD 5.17% 6.08%
1 Year 5.38% 6.50%
5 Year -22.42% 9.82%
Include dividend return
Market Analysis

Analyst Ratings

There is no analyst rating data currently available for Haw Par Corporation Limited.

Valuation

Price to earnings (P/E) ratio

Current P/E
Historical Average P/E
16.6

Haw Par Corporation Limited's current P/E ratio of ∞x is higher than its historical average P/E ratio of 16.6x.

Price to book (P/B) ratio

Current P/B
0.7
Historical Average P/B
0.8

Haw Par Corporation Limited's current P/B ratio of 0.7x is lower than its historical average P/B ratio of 0.8x.

Earnings

Earnings Highlights

Full Year FY2023 Results Summary

  • Revenue: SGD 232.06M

    Increased 27% Year-on-Year

    Higher consumer spend on healthcare products

  • Net Profit: SGD 217M

    Increased 46% Year-on-Year

    Higher dividend income, interest income and improved gross margin from higher production volume

  • Return on Equity (ROE): 6%

    Increased 48% Year-on-Year

  • Dividend Per Share: SGD 0.40

    Increased 33% Year-on-Year

  • Debt to Equity Ratio: 1%

    Decreased 2% Year-on-Year

Earnings per share (EPS)

The latest earnings per share is $0.98, which is higher than the earnings per share of $0.67 in 2022.

Financials

Financial Statements

26 Feb 2024

Full Yearly Results

For period ending 31 Dec 2023

11 Aug 2023

Half Yearly Results

For period ending 30 Jun 2023

Annual Reports

02 Apr 2024

Sustainability Report

For period ending 31 Dec 2023

02 Apr 2024

Annual Report

For period ending 31 Dec 2023

News
Profile

Company Description

Haw Par Corporation Limited, a Singapore-grown multinational Group, is listed on the Singapore Exchange since 1969. Over the decades, the Group has been disciplined in asset rationalisation, organically growing its core businesses, and making selected acquisitions. Today, the Haw Par Group is an enterprise with a strong consumer healthcare business that promotes healthy lifestyles through its healthcare products. The largest contributor to the healthcare business comes from a brand that it owns—Tiger Balm. With a wide range of products available in over 100 countries, Tiger Balm is arguably the world’s leading and most versatile topical analgesic brand. Besides the consumer healthcare business, the Group also engages in the leisure business and holds significant investments in securities and properties. Leveraging on its financial strength and global business network, the Group is well-placed in its strategic direction to further expand its portfolio of operating businesses and drive growth through alliances with multinational partners and acquisitions of complementary brands and compelling business platforms.

FAQ

Hot stocks that may interest you